Paper published in a journal (Scientific congresses and symposiums)
A randomized double-blind study of denosumab compared with zoledronic acid in postmenopausal women with osteoporosis previously treated with oral bisphosphonate.
MILLER, P.D.; PANNACCIULLI, N.; BROWN, J.P. et al.
2016In Arthritis and Rheumatology, 67 (S10), p. 1181-1182
Peer Reviewed verified by ORBi
 

Files


Full Text
a randomized double blind study of denosumab compared with zoledronic acid in postmenopausal women with osteoporosis previously treated with oral bisphosphonate..pdf
Author postprint (90.22 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
General & internal medicine
Author, co-author :
MILLER, P.D.
PANNACCIULLI, N.
BROWN, J.P.
CZERWINSKI, E.
NEDERGAARD, B.S.
BOLOGNESE, M.A.
MALOUF, J.
BONE, H.G.
Reginster, Jean-Yves  ;  Université de Liège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
SINGER, A.
WANG, C.
WAGMAN, R.B.
CUMMINGS, S.R.
More authors (3 more) Less
Language :
English
Title :
A randomized double-blind study of denosumab compared with zoledronic acid in postmenopausal women with osteoporosis previously treated with oral bisphosphonate.
Publication date :
2016
Event name :
ACR/ARHP Annual Meeting
Event organizer :
American College of Rheumatology
Event place :
San Francisco, United States
Event date :
du 6 au 11 novembre 2015
Audience :
International
Journal title :
Arthritis and Rheumatology
ISSN :
2326-5191
eISSN :
2326-5205
Publisher :
Wiley
Volume :
67
Issue :
S10
Pages :
1181-1182
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 07 January 2016

Statistics


Number of views
76 (1 by ULiège)
Number of downloads
1 (0 by ULiège)

Bibliography


Similar publications



Contact ORBi